Few people with a cause walk the talk as boldly and graciously as Christine Von Raesfeld, Christine is a pillar of patient advocacy and allyship in the rare and chronic disease community. Through the lens of her lived experiences in healthcare, she has become a champion for patient voices, diversity and inclusion in clinical research, and equitable patient-sponsor partnerships. Christine has brought her unique perspective and honed expertise to countless roles as a featured speaker for numerous conferences on topics ranging from clinical trial recruitment to data & digital rights, from a true patient perspective. She serves as an e-patient scholar with Stanford MedicineX and a Committee Member with the Partnership for Quality Measures (CMS) among other roles. Wherever possible, Christine generates momentum toward progress along her patient advocacy jouney and has become a thought leader worldwide, stimulating dialog on a range of topics relevant to patients, clinicians, and industry.  As a patient advisor, Christine has assisted several initiatives including the Stanford "Humanwide" Precision Medicine Program and the NIH All of Us Research Program and serves as a board member/advisor to multiple organizations and startups. She helped to co-author the patient-led AI Rights Initiative with the Light Collective and focuses on data/digital rights and personalized/precision medicine. For her many contributions to her field, she has been named one of the top 100 Women of Influence by Silicon Valley Business Journal, Silicon Valley Community Hero, a member of the 2021 HIMSS Future50, and one of Medika Life's 50 most influential voices in healthcare.